Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics
2021 · Journal of Cancer · 63 citations
https://doi.org/10.7150/jca.52993
A
Analyn Lizaso
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
440
Citations
12
h-index
15
i10-index
Analyn Lizaso is an academic researcher from Burning Rock Biotech (China). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & Lung Cancer Diagnosis and Treatment. The author has an h-index of 12, co-authored 42 publications.
Papers by this author
worksIndividualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
2023 · BMC Medicine · 22 citations
https://doi.org/10.1186/s12916-023-02954-z
Molecular characterization and clinical outcomes in EGFR-mutant de novo MET-overexpressed advanced non-small-cell lung cancer
2021 · ESMO Open · 7 citations
https://doi.org/10.1016/j.esmoop.2021.100347
Corrigendum to “Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma” [Modern Pathology. 2022;35(9):1181-1192]
2024 · Modern Pathology · 0 citations
https://doi.org/10.1016/j.modpat.2023.100407
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat